Correlation Between Bellerophon Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both Bellerophon Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellerophon Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellerophon Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on Bellerophon Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellerophon Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellerophon Therapeutics and Bio Path.
Diversification Opportunities for Bellerophon Therapeutics and Bio Path
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bellerophon and Bio is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Bellerophon Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Bellerophon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellerophon Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Bellerophon Therapeutics i.e., Bellerophon Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between Bellerophon Therapeutics and Bio Path
Given the investment horizon of 90 days Bellerophon Therapeutics is expected to generate 1.46 times more return on investment than Bio Path. However, Bellerophon Therapeutics is 1.46 times more volatile than Bio Path Holdings. It trades about 0.06 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.04 per unit of risk. If you would invest 147.00 in Bellerophon Therapeutics on November 2, 2024 and sell it today you would lose (76.00) from holding Bellerophon Therapeutics or give up 51.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Bellerophon Therapeutics vs. Bio Path Holdings
Performance |
| Timeline |
| Bellerophon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Bio Path Holdings |
Bellerophon Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bellerophon Therapeutics and Bio Path
The main advantage of trading using opposite Bellerophon Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellerophon Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Bellerophon Therapeutics vs. Bio Path Holdings | Bellerophon Therapeutics vs. Capricor Therapeutics | Bellerophon Therapeutics vs. NextCure | Bellerophon Therapeutics vs. Zura Bio Limited |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |